Single Dose Enteral Tranexamic Acid in Critically Ill Patients
Status:
Terminated
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The premise of this study is that enteral tranexamic acid will help to maintain small bowel
integrity, which is often compromised by critical illness due to inadequate cardiovascular
perfusion (i.e., shock), and that maintenance of small bowel integrity will decrease
morbidity in critically ill patients.